Baines M, Oliver DJ, Carter RL.Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet1985; 2: 990-993.
2.
Bulbring E, Crema A.The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J Physiol1959; 146: 18-28.
3.
Matia I, Balaz P, Jackanin S, Rybarova E, Kron I, Pomfry Met al.Serotonin levels in the small bowel mucosa as a marker of ischaemic injury during small bowel preservation. Ann Transplant2004; 9: 48-51.
4.
Cubeddu LX.Serotonin mechanisms in chemotherapy-induced emesis in cancer patients. Oncology1996; 53: 18-25.
5.
Prasad CN, Roy SK, Deenath PK, Sanyal AK.Importance of plasma serotonin in intestinal obstruction. Indian J Pharmacol1977; 9: 11-16.
6.
Hutchinson SMW, Beattie G, Shearing CH.Increased serotonin excretion in patients with ovarian carcinoma and intestinal obstruction. Palliat Med1995; 9: 67-68.
7.
Carling RS, Degg TJ, Allen KR, Bax ND, Barth JH.Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem2002; 39: 577-582.
8.
Lee MS, Cheng FC, Yeh HZ, Liou TY, Lui JH.Determination of plasma serotonin and 5-hydroxyindo-leacetic acid in healthy subjects and cancer patients. Clin Chem2000; 46: 422-423.
9.
Cubeddu LX, Hoffman IS.Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics. J Clin Pharmacol1993; 33: 691-697.
